Recommended Events
|
| Thanks to SoCalBio Weekly Update Sponsor |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
(SoCalBio)
enany@socalbio.org
www.socalbio.org
| June 2nd, 2010  |
Featured News Story
| Stem Cell Center Brings Incubator Hopes for UCI 
Could the University of California, Irvine's new stem cell center turn research into business for the school? " That is absolutely one of the things we would like to have happen," said Peter Donovan (photo above), co-director of UC Irvine's Sue and Bill Gross Hall. The center, an $80 million, 100,000-square-foot building that debuted this month, could be the source of companies or licensed technology and possible treatments of spinal cord injuries, diabetes and Alzheimer's disease, among others. That could spur revenue that flows back to the university, Donovan said... Read article at the OCBJ
|
Opinion
| The Genome Project is 10 Years Old - Where is the Health Care Revolution?
 Ten years ago, the completion of the Human Genome Project promised to usher in a whole new era of heath care. Revolutionary gene therapies would soon conquer everything from cancer and heart disease to diabetes and autoimmunity. A roll-call of our genes would unlock the causes (and the solutions) to death and disease. But a decade on, most of these hopes have failed to materialize, and most of our lives haven't changed. So where's the revolution? .... Find the answer at the Singularity Hub
|
SoCalBio Golf Classic
| SoCalBio/Image 2000 Golf Classic
(ending with with reception and dinner)
Old Ranch Country Club in Seal Beach
Thanks to Title Sponsor
Join your medtech and biotech colleagues and friends for a great day of golf in one of the exquisite courses in Southern California while you show your support for the bioscience industry, the Multiple Sclerosis Society and SoCalBio.
 This event will conclude with a cocktail reception and dinner featuring Dr. Leslie Weiner of USC who will address attendees about new multiple sclerosis treatment modalities
|
Welcome New SoCalBio Members
| West Coast Clinical Trials (Cypress)
 West Coast Clinical Trials (WCCT) is a privately owned independent Phase I-IV CRO. WCCT has a unique focus on ethno-bridging studies including Japanese bridging/population trials. In addition, the firm has extensive experience with healthy volunteer studies including First-in-Human (FIH) as well as specific therapeutic expertise in Allergy, Asthma, Infectious Disease, Pediatric, Renal, Serial ECGs, and Vaccines... Learn more |
 |  |
RSVP for Mixers and Executive Forums
| June 22, 11:00 AM - 2:00 PM
SoCalBio Luncheon and Roundtable Discussion for Cardiovascular Company Executives
DevicePharm (Irvine, CA)
The luncheon & Roundtable is solely for solid
peer-to-peer information exchange and debate. The
roundtable is open to SoCalBio member companies and invited executives affiliated with non-member companies.
Click to RSVP
(Only executives in cardiovascular companies)
*********************************************************
June 30, 4:00 to 7:00 PM
SoCalBio Networking Forum in Ventura County
Click here to RSVP
*********************************************************
July 23, 8:00 AM to 12:00 Noon
SoCalBio Open House
Wilshire Grand Hotel in Downtown Los Angeles
Learn how SoCalBio's Group Purchasing Program can slow your company's burn rate and cut down the cost of doing business; and get detailed insight into how SoCalBio can help your organization succeed.
RSVP Now
|
| |
From the Lab Bench
| John Wayne Cancer Institute Scientist Leads Studies of C6-Ceramide Nanoliposomes to Deliver a One-Two Punch to Knock Out Cancer
Myles C. Cabot, Ph.D., director of the Laboratory of Experimental Therapeutics at JWCI, is testing nanoliposomes, particles with diameters measured in billionths of a meter, in a two-part anticancer system. With an exterior coat of C6-ceramide, each particle is like a tiny bubble that can encapsulate other drugs inside itself. The researchers will fill the bubbles with tamoxifen, a well-known anticancer drug that prevents the unwanted conversion of ceramide into its inactive form. As C6-ceramide is relatively soluble, it dissolves, releasing the tamoxifen. The combination should effectively increase ceramide's residence time, allowing it to kill the cancer without being deactivated.... Read more |
Moving in
| CardiAQ Valve Technologies Moves its Headquarters to Irvine, California
CardiAQ Valve Technologies, a developer transcatheter mitral valve implantation technology, announced that it has established operations in Irvine, Calif. The company is moving to a 8,500 sq ft facility that was previously occupied by CoreValve before the latter's acquisition by Medtronic ... Read more |
Financing
| ReVision Optics Raises $35 Million
The Lake Forest, Calif.-based maker of implantable products to correct and maintain vision, has raised $35 million in fifth-round funding. ProQuest Investments led the round, and was joined by return backers Domain Associates, Canaan Partners and InterWest Partners. The company previously raised $40 million... Read more |
Going Public
| Pasadena-Based GenMark Diagnostics (AKA Osmetech) Commenced Trading on the Nasdaq GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced last week that its initial public offering of 4,600,000 shares of its common stock was priced at $6.00 per share. The shares commenced trading on May 28 on the NASDAQ Global Market under the ticker symbol "GNMK" .... Read more |
CE Mark
| Applied BioCode Receives the CE Mark for its Barcoded Magnetic Beads Multiplex Testing System The Santa Fe Springs-Based company announced that its BioCode-1000 Analyzer with the Barcoded Magnetic Beads (BMB) multiplex technology has received the CE Mark. This system is intended for research use only, but with a wide variety of biological applications to assist those focused on molecular diagnostics, gene mutation analysis, drug resistance genotyping, and pharmaceutical drug discovery ... Read moreEdwards Lifesciences Announces Receipt of CE Mark for Pulmonic Transcatheter Valve
The valve is designed to be an alternative to surgical valve replacement for patients suffering from congenital heart disease of the pulmonic valve and leverages the company's transcatheter valve technology, which has been used in more than 5,000 cases around the world.... Read more |
Product Approval
| FDA clears Amgen's bone-strengthening drug, Prolia
The Food and Drug Administration yesterday approved Amgen's bone strengthening drug, Prolia, for postmenopausal women at risk for fractures, a potential blockbuster market. The injectable drug is given once every six months to increase bone mass and strength. Analysts think Prolia should bring Amgen billions in revenue after it is launched. Sales of the company's former top sellers, the anemia drugs, Aranesp and Epogen, have dropped in recent years due to safety concerns and label restrictions... Read more
Watson gets FDA approval for generic Valtrex Watson (Corona, Calif.) received FDA approval for a generic version of GlaxoSmithKline's herpes treatment Valtrex. Valtrex had sales of about $1.8 billion in the U.S. during the 12-month period ending in March... Read more |
Personnel
| Viral Genetics Appoints Dr. Baruch S. Blumberg to its Advisory Board Nobel Laureate Dr. Baruch S. Blumberg, MD, PhD., has joined the advisory board of Viral Genetics, Inc. which is headquartered in San Marino, California. Dr. Blumberg won the 1976 Nobel Prize in Medicine for the discovery of the Hepatitis-B virus. He is the second Nobel Laureate to join the advisory board of Viral Genetics ... Read more |
| Jobs Available | Second Sight Medical Products (Sylmar)
A medical device company developing a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations, such as Retinitis Pigmentosa is seeking to fill the following positions: - Customer Service Manager
- Director of Quality Assurance
- Experimental Psychophysicist
- Low Vision Specialist
- Neurostimulation Scientist
- Vision Scientist
For more information and to apply, click hereQuantimetrix (Redondo Beach)
A manufacturer of clinical diagnostics products is looking for:
Sales Representative Administrative Assistant
Applied BioCode (Santa Fe Springs)
A biotech company formed to research, develop, and commercialize its Barcoded Magnetic Bead (BMB) technology for the medical diagnostic and life sciences markets is seeking:
- Product Marketing Manager - Bioresearch and Clinical Diagnostics
- Molecular Biologist
For more information and to apply, click here |
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
